https://i.vimeocdn.com/video/1974782783-8ab2634f76b16ed9e7ce901e35e76abc526e3935251353c85e49e70c33a84d87-d

Gene Editing Therapeutics

Pioneering Genetic Medicine Through Gene Editing Technologies.

Gene Editing Therapeutics

Pioneering Genetic Medicine Through Gene Editing Technologies.

About Us

Gene Editing Therapeutics (GETx) is pioneering gene editing innovations to provide effective treatments for genetic diseases.

Gene Editing Therapeutics is a biotech spin-out from the University of Adelaide, dedicated to revolutionising gene editing therapies. We leverage cutting-edge technology to enhance precision, maximise therapeutic impact, and uphold the highest safety standards. Our mission is to develop safe, effective, and transformative treatments for genetic disorders—offering patients renewed hope for a healthier, brighter future.

Our R&D Works & Expertise

Our world-class R&D team, led by leading CRISPR gene editing experts, is dedicated to pioneering the most efficient, scalable, and safe gene editing technologies to transform the treatment of genetic diseases.

Breakthrough Innovation – We push the boundaries of gene editing by developing novel technologies, discovering promising therapeutic candidates, and expanding applications to a broader range of genetic disorders.

Customised Therapeutics – Our team specialises in bespoke research solutions, designing tailored gene editing strategies to address specific mutations and meet unique clinical needs.

High Translatability – We employ multiple strategies to ensure seamless clinical translation, including the use of humanised mouse models that accurately mimic human genetic mutations. These models enhance the predictability and reliability of our in vivo studies, contributing to the successful development of clinically viable therapies.

Gene Editing Therapeutics

Gene Editing Therapeutics

About Us

Innovative Gene Editing Technologies

Our R&D Works & Expertise

Connect With Us

This website uses cookies.